Establishing a process for the use of hydroxyurea in pediatric sickle cell patients in Angola

Establishing a process for the use of hydroxyurea in pediatric sickle cell patients in Angola

Bibliographic Details
Main Authors:	R. Beaty, G. Airewele, D. Nirenberg, M.P. Noli, S. Kahan, E. Ishigami, M. Cubbage, W. Zhang, K. Wilson-Lewis
Format:	Article
Language:	English
Published:	Ubiquity Press 2016-08-01
Series:	Annals of Global Health
Online Access:	https://annalsofglobalhealth.org/articles/1065

Similar Items

Pilot program of newborn screening for sickle cell disease in angola- Angola Sickle Cell Initiative (ASCI)
by: D. Nirenberg, et al.
Published: (2015-03-01)

5595849 THE GUT MICROBIOME AND HYDROXYUREA EFFECT ON SICKLE CELL DISEASE CHILDREN FROM ANGOLA
by: M. Brito, et al.
Published: (2023-04-01)

Nutritional Evaluation of Pediatric Patients with Sickle Cell Disease Treated with Hydroxyurea
by: Belkis Lázara Rodríguez Jorge, et al.
Published: (2021-03-01)

Nutritional Evaluation of Pediatric Patients with Sickle Cell Disease Treated with Hydroxyurea
by: Belkis Lázara Rodríguez Jorge, et al.
Published: (2021-03-01)

Hydroxyurea use and hospitalization trends in a comprehensive pediatric sickle cell program.
by: Kerri A Nottage, et al.
Published: (2013-01-01)

Developing a logistical plan for deploying full and part-time healthcare providers abroad – Texas Children’s Cancer and Hematology Centers’s experience
by: E. Ishigami, et al.
Published: (2016-08-01)

Minimal doses of hydroxyurea for sickle cell disease
by: C.S.P. Lima, et al.
Published: (1997-08-01)

Adherence to Hydroxyurea and Patients’ Perceptions of Sickle Cell Disease and Hydroxyurea: A Cross-Sectional Study
by: Mohammed Ali Madkhali, et al.
Published: (2024-01-01)

P1425: SYSTEMATIC INVESTIGATION OF HYDROXYUREA TREATMENT EFFECT IN PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE
by: Varsha Bhat, et al.
Published: (2023-08-01)

Hydroxyurea for sickle-cell anaemia in Africa: mind the gap
by: Stephen K Obaro
Published: (2015-03-01)

Hydroxyurea and sickle cell anemia: effect on quality of life
by: Pegelow Charles H, et al.
Published: (2006-08-01)

Evaluation of hydroxyurea genotoxicity in patients with sickle cell disease
by: Emanuel Almeida Moreira de Oliveira, et al.

Hydroxyurea granules for the management of sickle cell disease in children
by: Grace Lovia Allotey-Babington, et al.
Published: (2022-07-01)

The influence of hydroxyurea on oxidative stress in sickle cell anemia
by: Lidiane de Souza Torres, et al.
Published: (2012-01-01)

The influence of hydroxyurea on oxidative stress in sickle cell anemia
by: Lidiane de Souza Torres, et al.
Published: (2012-01-01)

Mutagenicity of hydroxyurea in lymphocytes from patients with sickle cell disease
by: Khayat André Salim, et al.
Published: (2004-01-01)

The burden and quality of life of caregivers of sickle cell anemia patients taking hydroxyurea versus those not taking hydroxyurea
by: Luiz Bernardino Lima da Silva, et al.
Published: (2012-01-01)

Mathematical Modeling of Hydroxyurea Therapy in Individuals with Sickle Cell Disease
by: Akancha Pandey, et al.
Published: (2022-05-01)

Determining of the Hydroxyurea Effluence on TCD Parameters of Sickle Cell Patients
by: Nasser Sharafadinzadeh, et al.
Published: (2009-07-01)

Is Hydroxyurea Treatment Changing the Life of Children with Sickle Cell Disease?
by: Mohammed Ali Al Sabbah, et al.
Published: (2023-07-01)

Hydroxyurea treatment for adult sickle cell anemia patients in Kinshasa
by: Paul Lumbala Kabuyi, et al.
Published: (2023-08-01)

Cellular biophysical markers of hydroxyurea treatment in sickle cell disease
by: Du, E., et al.
Published: (2018)

EVALUATION OF THE LEUKOCYTE INDEX IN SICKLE CELL ANEMIA WITH THE USE OF HYDROXYUREA
by: JO Rios, et al.
Published: (2021-10-01)

Concurrent use of hydroxyurea and deferasirox in Californians with sickle cell disease
by: Trisha E. Wong, et al.
Published: (2021-09-01)

Cellular normoxic biophysical markers of hydroxyurea treatment in sickle cell disease
by: Hosseini, Poorya, et al.
Published: (2018)

Evidence review of hydroxyurea for the prevention of sickle cell complications in low-income countries.
by: Mulaku, M, et al.
Published: (2013)

Evidence review of hydroxyurea for the prevention of sickle cell complications in low-income countries
by: Mulaku, M, et al.
Published: (2013)

Effect of Hydroxyurea Treatment on the Inflammatory Markers Among Children With Sickle Cell Disease
by: Asmaa M. Zahran MD, et al.
Published: (2020-01-01)

Hydroxyurea utilization and dose optimization in children with sickle cell disease (SCD)
by: Nour Alotaibi, et al.
Published: (2023-01-01)

A systematic review on hydroxyurea therapy for sickle cell disease in India
by: Apoorva Pandey, et al.
Published: (2022-01-01)

Pure Erythroid Leukemia in a Sickle Cell Patient Treated with Hydroxyurea
by: Dhiraj Kumar Yadav, et al.
Published: (2020-07-01)

Menopause in Brazilian women with sickle cell anemia with and without hydroxyurea therapy
by: Ana Mach Queiroz, et al.
Published: (2021-07-01)

Neutrophils remain detrimentally active in hydroxyurea-treated patients with sickle cell disease.
by: Emilia Alina Barbu, et al.
Published: (2019-01-01)

Moderate dose of hydroxyurea in children with sickle cell disease and stroke. Preliminary results
by: Sergio Machín-García, et al.

PI-03: THE EFFECT OF HYDROXYUREA IN THE GUT MICROBIOME OF ANGOLAN CHILDREN WITH SICKLE CELL DISEASE
by: DELGADINHO M., et al.
Published: (2022-08-01)

Higher hydroxyurea adherence among young adults with sickle cell disease compared to children and adolescents
by: Paavani S. Reddy, et al.
Published: (2022-12-01)

P-034: EFFECTS OF HYDROXYUREA ON SKELETAL MUSCLE MICROVASCULATURE OF MICE WITH SICKLE CELL DISEASE
by: RICCETTI M., et al.
Published: (2022-08-01)

Impact of hydroxyurea on clinical and biological parameters of sickle cell anemia in children in Abidjan
by: MIREILLE YAYO- AYE, et al.
Published: (2024-02-01)

Leveraging mathematical modeling to analyze nonadherence for hydroxyurea therapy in sickle cell disease
by: Akancha Pandey, et al.
Published: (2023-06-01)

Evaluation of the concentration of malondialdehyde and nitrite in patients with sickle cell anemia treated or not with hydroxyurea
by: Darcielle Bruna Dias Elias, et al.
Published: (2010-12-01)